Esters, retroesters, and a retroamide of palmitic acid: Pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase

Journal of Medicinal Chemistry

Volumn 46, Issue 21, 2003, Pages 4373-4376

  Vandevoorde, Séverine ^a   Tsuboi, Kazuhito ^b   Ueda, Natsuo ^b   Jonsson, Kent Olov ^c   Fowler, Christopher J ^c   Lambert, Didier M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b KAGAWA UNIVERSITY   (Japan)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; AMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CYCLOHEXYL HEXADECANOATE; ENZYME INHIBITOR; ESTER; HEXADECYL PROPIONATE; HYDROLASE; N (3 HYDROXYPROPIONYL)PENTADECANAMIDE; N PALMITOYLETHANOLAMINE HYDROLASE; N PALMITOYLETHANOLAMINE HYDROLASE INHIBITOR; PALMIDROL; PALMITIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; RECEPTOR AFFINITY; RECEPTOR BINDING;

AMIDES; AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BINDING, COMPETITIVE; BRAIN; CALCIUM CHANNEL BLOCKERS; CHO CELLS; CRICETINAE; CYCLOHEXANOLS; ENZYME INHIBITORS; ESTERS; HUMANS; INDICATORS AND REAGENTS; LUNG; MORPHOLINES; NAPHTHALENES; PALMITATES; POLYUNSATURATED ALKAMIDES; RATS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0141923653     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0340795     Document Type: Article

References (23)

1. Devane, W.A.; Hanus, L.; Breuer, A.; Pertwee, R.G.; Stevenson, L.A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R.Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946-1949.
2. Di Marzo, V.; Bisogno, T.; De Petrocellis, L.; Melck, D.; Martin, B. R. Cannabimimetic fatty acid derivatives: the anandamide family and other "endocannabinoids". Curr. Med. Chem. 1999, 6, 721-744.
3. Giuffrida, A.; Beltramo, M.; Piomelli, D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J. Pharmacol. Exp Ther. 2001, 298, 7-14.
4. Bisogno, T.; Maurelli, S.; Melck, D.; De Petrocellis, L.; Di Marzo, V. Biosynthesis, uptake and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem. 1997, 272, 3315-3323.
5. Ueda, N.; Kurahashi, Y.; Yamamoto, S.; Tokunaga, T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 1995, 270, 23823-23827.
6. Deutsch, D. G.; Chin, S. A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 1993, 46, 791-796.
7. Deutsch, D. G.; Omeir, R.; Arreaza, G.; Salehani, D.; Prestwich, G. D.; Huang, Z.; Howlett, A. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem. Pharmacol. 1997, 53, 255-260.
8. De Petrocellis, L.; Melck, D.; Ueda, N.; Maurelli, S.; Kurahashi, Y.; Yamamoto, S.; Marino, G.; Di Marzo, V. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochem. Biophys. Res. Commun. 1997, 231, 82-88.
9. Bracey, M. H.; Hanson, M. A.; Masuda, K. R.; Stevens, R. C.; Cravatt, B. F. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 2002, 298, 1793-1796.
10. Lambert, D. M.; Di Marzo, V. The palmitoylethanolamide and oleamide enigmas: Are these two fatty acid amides cannabimimetic? Curr. Med. Chem. 1999, 6, 757-773.
11. 2 cannabinoid, as potential ligands for the cannabinoid receptors. Biochim. Biophys. Acta 2001, 1440, 266-274.
12. Calignano, A.; La Rana, G.; Giuffrida, A.; Piomelli, D. Control of pain initiation by endogenous cannabinoids. Nature 1998, 394, 277-281.
13. Rodriguez De Fonseca, F.; Navarro, M.; Gomez, R.; Escuredo, L.; Nava, F. ; Fu, J.; Murillo-Rodriguez, E.; Giuffrida, A.; Lo Verme, J.; Gaetani, S.; Kathuria, S.; Gall, C.; Piomelli, D. An anorexic lipid mediator regulated by feeding. Nature 2001, 414, 209-212.
14. Fowler, C.J.; Jonsson, K.-O.; Tiger, G. Fatty acid amide hydrolase: biochemistry, pharmacology and therapeutic possibilities for an enzyme hydrolyzing anandamide. Biochem. Pharmacol. 2001, 62, 517-526.
15. Ueda, N. Endocannabinoid hydrolases. Prostaglandins Other Lipid Mediat. 2002, 68/69, 521-534.
16. Desarnaud, F.; Cadas, H.; Piomelli, D. Anandamide amidohydrolase activity in rat brain microsomes. J. Biol. Chem. 1995, 270, 6030-6035.
17. Katayama, K.; Ueda, N.; Katoh, I.; Yamamoto, S. Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme.Biochim. Biophys. Acta 1999, 1440, 205-214.
18. Ueda, N.; Yamanaka, K.; Terasawa, Y.; Yamamoto, S. An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. FEBS Lett. 1999, 454, 267-270.
19. Ueda, N.; Yamanaka, K.; Yamamoto, S. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous antiinflammatory substance. J. Biol. Chem. 2001, 276, 35552-35557.
20. 2 cannabinoid receptors and metabolic stability. J. Med. Chem. 1998, 41, 5353-5361.
21. Jonsson, K.O.; Vandevoorde, S.; Lambert, D.M.; Tiger, G.; Fowler, C. J. Effect of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br. J. Pharmacol. 2001, 133, 1263-1275.
22. Vandevoorde, S.; Jonsson, K.O.; Fowler, C. J.; Lambert, D.M. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide. J. Med. Chem. 2003, 46, 1440-1448.
23. Rakhshan, F.; Day, T. A.; Blakely, R. D.; Barker, E. L. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J. Pharmacol. Exp. Ther. 2000, 960-967.